COMMON STOCK UNITS, COMMON STOCK AND COMMON STOCK WARRANTS	3 Months Ended
Mar. 31, 2017
COMMON STOCK UNITS, COMMON STOCK AND COMMON STOCK WARRANTS
COMMON STOCK UNITS, COMMON STOCK AND COMMON STOCK WARRANTS	NOTE 7 — COMMON STOCK UNITS, COMMON STOCK AND COMMON STOCK WARRANTS During the three months ended March 31, 2017, we issued 556,590 shares of common stock pursuant to stock awards under the 2006 Equity Incentive Plan. During the year ended December 31, 2016, 1,312,894 shares of common stock were issued pursuant to stock awards under the 2006 Equity Incentive Plan. On December 26, 2014, the Company issued 8.5 million warrants in connection with the private placement of its Convertible Senior Promissory Notes described in Note 6 at a price of $1.00 per share and having a relative fair value of $0.8 million. In addition, the $0.8 million value placed on the warrants was considered a debt discount and is being amortized over the expected redemption period. On November 24, 2015, the Company issued 80.0 million warrants to AMER in connection with the closing of the amended Investment Agreement at a price of $0.50 per share and a relative fair value of $0.5 million, resulting in an entry to additional paid-in capital. Of the warrants outstanding at March 31, 2017, 8.5 million are exercisable at $1.00 per share at any time through their expiration on December 26, 2019, 1.0 million are exercisable at $5.00 per share once General Moly has received financing necessary for the commencement of commercial production at the Mt. Hope Project and will expire one year thereafter, and the 80.0 million AMER Warrants were scheduled to become exercisable upon availability of the Bank Loan, should such availability occur prior to April 17, 2017, the second anniversary of the AMER Investment Agreement, as described in Note 1 above, and would expire five years thereafter. As the Bank Loan was not available on this date, on April 17, 2017, the Company and AMER entered into a First Amendment (the “Amendment”) to the AMER warrants. The Amendment extends the deadline two months for satisfaction of all conditions to the vesting of the warrants from April 17, 2017 to June 17, 2017. The Company and AMER agreed on a short extension of the expiration of the warrants while they discuss a longer-term modification of the other agreements between the parties, supportive of their existing strategic partnership. Pursuant to our amended Certificate of Incorporation, approved by the stockholders at the general meeting of June 30, 2015, we are authorized to issue 650.0 million shares of $0.001 par value common stock. All shares have equal voting rights, are non-assessable and have one vote per share. Voting rights are not cumulative and therefore, the holders of more than 50% of the common stock could, if they choose to do so, elect all of the directors of the Company. The Certificate of Amendment was filed in Delaware on July 14, 2015.

NOTE 7 — COMMON STOCK UNITS, COMMON STOCK AND COMMON STOCK WARRANTS

During the three months ended March 31, 2017, we issued 556,590 shares of common stock pursuant to stock awards under the 2006 Equity Incentive Plan.

During the year ended December 31, 2016, 1,312,894 shares of common stock were issued pursuant to stock awards under the 2006 Equity Incentive Plan.

On December 26, 2014, the Company issued 8.5 million warrants in connection with the private placement of its Convertible Senior Promissory Notes described in Note 6 at a price of $1.00 per share and having a relative fair value of $0.8 million. In addition, the $0.8 million value placed on the warrants was considered a debt discount and is being amortized over the expected redemption period.

On November 24, 2015, the Company issued 80.0 million warrants to AMER in connection with the closing of the amended Investment Agreement at a price of $0.50 per share and a relative fair value of $0.5 million, resulting in an entry to additional paid-in capital.

Of the warrants outstanding at March 31, 2017, 8.5 million are exercisable at $1.00 per share at any time through their expiration on December 26, 2019, 1.0 million are exercisable at $5.00 per share once General Moly has received financing necessary for the commencement of commercial production at the Mt. Hope Project and will expire one year thereafter, and the 80.0 million AMER Warrants were scheduled to become exercisable upon availability of the Bank Loan, should such availability occur prior to April 17, 2017, the second anniversary of the AMER Investment Agreement, as described in Note 1 above, and would expire five years thereafter. As the Bank Loan was not available on this date, on April 17, 2017, the Company and AMER entered into a First Amendment (the “Amendment”) to the AMER warrants. The Amendment extends the deadline two months for satisfaction of all conditions to the vesting of the warrants from April 17, 2017 to June 17, 2017. The Company and AMER agreed on a short extension of the expiration of the warrants while they discuss a longer-term modification of the other agreements between the parties, supportive of their existing strategic partnership.

Pursuant to our amended Certificate of Incorporation, approved by the stockholders at the general meeting of June 30, 2015, we are authorized to issue 650.0 million shares of $0.001 par value common stock. All shares have equal voting rights, are non-assessable and have one vote per share. Voting rights are not cumulative and therefore, the holders of more than 50% of the common stock could, if they choose to do so, elect all of the directors of the Company. The Certificate of Amendment was filed in Delaware on July 14, 2015.